Consensus EPS · Q2 2026
$2.09
Consensus revenue · Q2 2026
$1.5B
Analysts
13
Expected report
Jul 28, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 13 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $1.3B | $1.5B | $1.6B |
| EPS | $1.51 | $2.09 | $2.84 |
| EBITDA | $300.3M | $316.1M | $368.1M |
| EBIT | $272.1M | $286.5M | $333.5M |
| Net income | $362.9M | $444.6M | $526.3M |
- Revenue$1.5B
- EPS$2.09
- EBITDA$316.1M
- EBIT$286.5M
- Net income$444.6M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $1.3B | $1.2B | +4.7% | $1.81 | $1.34 | +35.1% |
- Q1 2026+4.7%+35.1%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Incyte (INCY) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 4 analysts.
- Low
- $99.00
- Consensus
- $113.09
- Median
- $110.00
- High
- $140.00
- Current
- $115.79
- Upside
- -2.3%
Upside calculated vs most recent trading price of $115.79.
Consensus across all covering analysts. See the ranking ›
Analyst ratings
Consensus: Buy — based on 44 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 21, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jul 14, 2026 | Barclays | maintain | Overweight | Overweight |
| Jul 13, 2026 | BMO Capital | maintain | Market Perform | Market Perform |
| Jul 7, 2026 | RBC Capital | maintain | Sector Perform | Sector Perform |
| Jun 29, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jun 26, 2026 | UBS | maintain | Neutral | Neutral |
| Jun 24, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jun 22, 2026 | Truist Securities | maintain | Hold | Hold |
| Jun 22, 2026 | BMO Capital | upgrade | Underperform | Market Perform |
| Jun 9, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
- Jul 21, 2026HC Wainwright & Co.Buy
- Jul 14, 2026BarclaysOverweight
- Jul 13, 2026BMO CapitalMarket Perform
- Jul 7, 2026RBC CapitalSector Perform
- Jun 29, 2026HC Wainwright & Co.Buy
- Jun 26, 2026UBSNeutral
- Jun 24, 2026HC Wainwright & Co.Buy
- Jun 22, 2026Truist SecuritiesHold
- Jun 22, 2026BMO CapitalMarket Perform
- Jun 9, 2026HC Wainwright & Co.Buy
Frequently asked questions
Incyte (INCY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.